Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward? [PDF]
Tigyi G +6 more
europepmc +1 more source
Inhibition of lysophosphatidic acid receptor 1-3 deteriorates experimental autoimmune encephalomyelitis by inducing oxidative stress. [PDF]
Choi JH +6 more
europepmc +1 more source
Corrigendum to "Inhibition of lysophosphatidic acid receptor 1 attenuates neuroinflammation via PGE2/EP2/NOX2 signalling and improves the outcome of intracerebral haemorrhage in mice" [Brain Behav. Immun. 91 (2021) 615-626]. [PDF]
Gao L +10 more
europepmc +1 more source
Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice. [PDF]
Khiar-Fernández N +14 more
europepmc +1 more source
Can a novel lysophosphatidic acid receptor 1 antagonist ACT in time to halt pulmonary fibrosis and improve breathing? [PDF]
Andresen BT.
europepmc +1 more source
Molecular mechanism of ligand recognition and activation of lysophosphatidic acid receptor LPAR6. [PDF]
Duan Y +5 more
europepmc +1 more source
Phospholipase A1 Member A Activates Fibroblast-like Synoviocytes through the Autotaxin-Lysophosphatidic Acid Receptor Axis. [PDF]
Zhao Y +9 more
europepmc +1 more source
Lysophosphatidic acid receptor 5 in insular cortex as a potential analgesic target in neuropathic pain. [PDF]
Wang B +10 more
europepmc +1 more source
Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer. [PDF]
Liu X +5 more
europepmc +1 more source
Generation of New Knock-Out Mouse Strains of <i>Lysophosphatidic Acid Receptor 1</i>. [PDF]
Antonopoulou G +6 more
europepmc +1 more source

